Quick Links
 
Operated by
Theme: Key Implications in Regulatory Environment

OMICS Group sustains the most foremost effective and also the current analyzed articles among the Open Access disciple. OMICS Publishing Group has been successful in revolutionizing the Open Access Journals and providing exposure to the scientific community by laying a platform along with 350 Journals, 30, 000 editorial team, 3.5 million readers and collaborated with more than 150 International Societies. The main aim of OMICS Group is to transform the world by circulating the knowledge related to science and technology all over the globe by different theme standards of living of the masses. Along with the Journals, OMICS Group also organizes Scientific Conferences which lay a perfect platform for all the International Audience to share their research ideas. OMICS Group International organizes over 100 International Conferences annually all over the world.

We are glad you were able to join us for the 5th International Conference and Exhibition on Pharmaceutical Regulatory Affairs during Aug 03-05, 2015 at Florida, USA. We hope that you enjoyed the worth of presentations and our hospitality. Our special thanks to our Editorial Board Members and Organizing Committee Members for providing advice on the agenda, and in supporting the conference.

Mark your calendars for the the 5th International Conference and Exhibition on Pharmaceutical Regulatory Affairs at Florida, USA from August 03-05, 2015.

We truly enjoyed having you and appearance forward to seeing you once more at Regulatory Affairs 2015!

Regards,
Regulatory Affairs 2015 Organizing Committee

Organizing Committee
Najy Alsayed
3E Pharmaceutical Consultancy
Switzerland
 
Vladimir Popov
ESMAR
Russia
 
Rama K Pidaparti
Wipro Technologies
USA
 
Stephen M Hall
S.M. Hall Consulting LLC
USA
Conference Highlights

Regulatory Affairs for Healthcare Products

Regulatory Requirements for Pharmaceuticals

Requirements for Medical Devices

IND, NDA, BLA, and ANDA

Biologics and Other Special Categories

Best Industry Practices

Business, Law Enforcement, and Education

Intellectual Property Management

Novel Strategies for Growth in the Pharma and Regulatory Environment

To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date
September 08-10, 2014
Sponsors & Exhibitors
Click Here for Sponsorship opportunites
Speaker Opportunity
Day 1                Day 2                Day 3
 
Available         Available         Available
Poster Opportunity
Media Partners

Regulatory Affairs-2014 is anticipated to be one of the best academic conferences in USA. The scientific sessions of the event is formulated with current regulatory aspects like API (Active Pharmaceutical Ingredients), scheduled drugs, over the counter drugs, subsequent process validation, audit process and inspection, common technical document, NDA (New Drug Application) and ANDA (Abbreviated New Drug Application) providing an up to date and in-depth information on the present scenario with pharma regulatory world. OMICS Group Regulatory Affairs-2014 has been exceptionally formulated with comprehensive scientific program including effectual keynote presentations, session-wise talks, poster presentations, special workshops and symposiums on contemporary pharmaceutical design controls which would lead for further advancements and technological innovations in regulatory affairs industry.

Regulatory Affairs-2014 is scheduled to commence at Raleigh, USA which is well known for its charm and beauty with many historical monuments and tourist attractions. OMICS Group International Pharmaceutical conferences cordially invite all the key players in the field of Regulatory industry to witness the grand event beyond a wonderful experience in the City of Oaks. See you shortly at Regulatory Affairs-2014.

Special Issues
All accepted abstracts will be published in respective OMICS Group Journals.
Abstracts will be provided with Digital Object Identifier by
Best viewed in Mozilla Firefox | Google Chrome | Opera | Safari | Above IE 7.0 version